New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer

Guopei Luo(Fudan University Shanghai Cancer Center), Xianjun Yu(Hubei University of Medicine), Jiang Long(Shanghai Medical College of Fudan University), Meng Guo(Northwest A&F University), Kun Fan(Shanghai Medical College of Fudan University), Jin Xu(Shanghai Medical College of Fudan University), Qiuyi Huang(Shanghai Medical College of Fudan University), Renquan Lu(Fudan University), Lu Yu(Shanghai Medical College of Fudan University), Zhiyao Fan(Shanghai Medical College of Fudan University), Chen Liu(Shanghai Medical College of Fudan University), Cheng He(Ministry of Natural Resources), Liang Liu(Shanghai Medical College of Fudan University), Kaizhou Jin(Shanghai Medical College of Fudan University), Chao Yang(China International Science and Technology Cooperation), Quanxing Ni(Shanghai Medical College of Fudan University), Andrew L. Warshaw(Massachusetts General Hospital)
Pancreatology
August 9, 2018
Cited by 79


Related Papers